Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsVancheswaran Gopalakrishnan, Jennifer A. Wargo|Science|2017Cited by 4.6k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Alexandre Reuben et al.|Cell|2018Cited by 2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T. Geller, Ravid Straussman, Michal Barzily-Rokni et al.|Science|2017Cited by 1.8k
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N. Spencer, Sarah Schneider, Jennifer L. McQuade et al.|Science|2021Cited by 876
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Takahiro Yamazaki et al.|Cell Research|2019Cited by 246